"Having damage-reduction responses as fundamental as needle and syringe exchange plans continues to be quite a problem for us in the last twenty years as a result of an exceedingly solid general public opposition to it."And CBC Information spoke with some of Individuals Global drug coverage industry experts to view what copyright may study from t